Impact of intravesical prostatic protrusion on therapeutic effects of Dutasteride in patients with benign prostatic hyperplasia

瞿根义,李晓东,许宁,蔡海,陈少豪,林云知,魏勇,郑清水,薛学义
DOI: https://doi.org/10.3760/cma.j.issn.0254-9026.2017.02.012
2017-01-01
Abstract:Objectives To evaluate the influence of intravesical protrusion of the prostate(IPP) on the response to treatment with 5a-reductase inhibitors in patients with benign prostatic hyperplasia (BPH).Methods Data on 154 patients with lower urinary tract symptoms secondary to BPH,treated with Dutasteride 0.5 mg/day,were retrospectively analyzed.Patient age,body mass index (BMI),international prostate symptom score(IPSS)before and after treatment,total prostate volume (TPV),transition zone volume (TZV),maximum urinary flow rate (Qmax),intravesical prostatic protrusion(IPP),prostate specific antigen(PSA)and other clinical indicators were collected.Logistic regression was used to analyze factors leading to acute urinary retention or surgical intervention.Results Of the 154 patients,41 (26.6%)developed acute urinary retention or required surgical intervention.The 1-year cumulative incidences of acute urinary retention or BPH-related surgery for the IPP<10 mm group and the IPP ≥10 mm group were 9.1 % and 70.5 %,respectively.Significant improvement in IPPS,TPV,TZV,Qmax and PSA was found in patients in the IPP < 10 mm group after treatment(P<0.001),while only TPV and TZV showed significant improvement in the IPP ≥10 mm group.Multivariate analysis revealed that IPP (OR =1.49;95 % CI:1.07-2.11,P =0.020) and preoperative Qmax(OR=0.32;95% CI:0.11-0.93,P=0.036)were good predictors of acute urinary retention and surgical treatment.Conclusions IPP can predict the results of Dutasteride treatment for benign prostatic hyperplasia.The efficacy of Dutasteride is poor for patients with IPP≥10 mm,who tend to develop acute urinary retention or require surgical intervention during treatment.
What problem does this paper attempt to address?